✦ LIBER ✦

Discovery of a Potent and Selective 5-ht5A Receptor Antagonist (I) by High-Throughput Chemistry.

✍ Scribed by David F. Corbett; Tom D. Heightman; Stephen F. Moss; Steven M. Bromidge; Sara A. Coggon; Mark J. Longley; Ana Maria Roa; Jennifer A. Williams; David R. Thomas

Publisher: John Wiley and Sons
Year: 2005
Weight: 9 KB
Volume: 36
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200551080

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Identification of a Potent and Selective

Identification of a Potent and Selective 5-HT1B Receptor Antagonist.

✍ Paul A. Wyman; Howard R. Marshall; Sean T. Flynn; Ron J. King; Mervyn Thompson; 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 14 KB 👁 2 views

Molecular Modeling Studies Focused on 5-

Molecular Modeling Studies Focused on 5-HT7 versus 5-HT1A Selectivity. Discovery of Novel Phenylpyrrole Derivatives with High Affinity for 5-HT7 Receptors.

✍ Alban Lepailleur; Ronan Bureau; Magalie Paillet-Loilier; Frederic Fabis; Nicolas 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 8 KB 👁 1 views

ChemInform Abstract: High Potent and Sel

ChemInform Abstract: High Potent and Selective Arylpiperazine Derivatives as Ligands for the 5-HT1A Receptor

✍ Maria Modica; Maria Santagati; Andrea Santagati; Filippo Russo; Alfredo Cagnotto 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 32 KB 👁 1 views

ChemInform Abstract: Arylpiperazide Deri

ChemInform Abstract: Arylpiperazide Derivatives of Phenylpiperazines as a New Class of Potent and Selective 5-HT1B Receptor Antagonists.

✍ C. JORAND-LEBRUN; P. J. PAUWELS; C. PALMIER; P. CHOPIN; C. MORET; M. MARIEN; S. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 35 KB 👁 1 views

ChemInform Abstract: Medicinal Chemistry

ChemInform Abstract: Medicinal Chemistry Research for a Discovery of Ramosetron Hydrochloride as a Novel Serotonine (5-HT3) Receptor Antagonist

✍ Mitsuaki Ohta 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 28 KB 👁 1 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable v

Discovery of Highly Potent, Selective, O

Discovery of Highly Potent, Selective, Orally Bioavailable, Metabotropic Glutamate Subtype 5 (mGlu5) Receptor Antagonists Devoid of Cytochrome P450 1A2 Inhibitory Activity.

✍ Nicholas D. Smith; et al. et al. 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 12 KB 👁 1 views